Affiliations 

  • 1 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  • 2 Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  • 3 Center for Reproductive Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
  • 4 Physiology Unit Faculty of Medicine Lincoln University College, Petaling Jaya, Malaysia
  • 5 Reproductive Medicine Unit, University of Schleswig-Holstein, Luebeck, Germany
  • 6 Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. Akhondi@Avicenna.ac.ir
Reprod Biol Endocrinol, 2017 Oct 02;15(1):77.
PMID: 28969648 DOI: 10.1186/s12958-017-0292-z

Abstract

BACKGROUND: Ooplasmic transfer (OT) technique or cytoplasmic transfer is an emerging technique with relative success, having a significant status in assisted reproduction. This technique had effectively paved the way to about 30 healthy births worldwide. Though OT has long been invented, proper evaluation of the efficacy and risks associated with this critical technique has not been explored properly until today. This review thereby put emphasis upon the applications, efficacy and adverse effects of OT techniques in human.

MAIN BODY: Available reports published between January 1982 and August 2017 has been reviewed and the impact of OT on assisted reproduction was evaluated. The results consisted of an update on the efficacy and concerns of OT, the debate on mitochondrial heteroplasmy, apoptosis, and risk of genetic and epigenetic alteration.

SHORT CONCLUSION: The application of OT technique in humans demands more clarity and further development of this technique may successfully prove its utility as an effective treatment for oocyte incompetence.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.